Publication | Open Access

Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy

Egfr Single-domain AntibodyTumor-penetrating PeptideDrug TargetingMedicineTumor TargetingCancer Drug PenetrationCancer TreatmentRadiation OncologyOncologyCell BiologyTumor MicroenvironmentCancer Growth